Revolution Medicines, Inc. (RVMD) › Cash & EquivalentsRevolution Medicines, Inc. (RVMD) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2018: $69.59M2019: $16.66M2020: $104.27M2021: $108.50M2022: $161.41M2023: $696.15M2024: $543.06M2025: $383.75M$383.75M2018Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$383.75M-29.3%2024$543.06M-22.0%2023$696.15M+331.3%2022$161.41M+48.8%2021$108.50M+4.1%2020$104.27M+525.9%2019$16.66M-76.1%2018$69.59M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share